El resultado de un estudio pionero avala la seguridad de los bioimplantes llamados PeriCord, hechos de células madre de cordón umbilical y pericardio de un donante de tejidos que hace que la zona af...
Read moreVarios grupos del CIBERCV han participado en un estudio liderado por el Instituto de Investigación Sanitaria INCLIVA, del Hospital Clínico Universitario de València, sobre el mejor tratamiento para...
Read moreOryzon Genomics announced today that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application to initiate a Phase I/II trial with iadademstat plus immune...
Read moreUn ensayo clínico financiado por los Institutos Nacionales de Salud de EE.UU. podría conducir al primer tratamiento eficaz para la enfermedad de calcificación arterial por deficiencia de CD73 .
Read moreA clinical trial with the prototype of the device shows that the use of this technology improves patient monitoring by nurses and reduces post-surgical complications.
Read moreA team of experts from the European consortium LIVERSCREEN, led by IDIBAPS and funded through the Horizon 2020 programme, used their expertise and all they learnt in the colorectal and lung cancer scr...
Read moreCuando en el contexto de la medicina hablamos de “plasma”, casi inmediatamente pensamos en plasma sanguíneo, y asociamos las terapias de plasma a las relacionadas con el uso de los componentes l...
Read moreSOM Biotech, a clinical-stage drug discovery and development company based on a unique proprietary Artificial Intelligence platform (SOMAIPRO®), is pleased to announce that the recruitment of the Pha...
Read moreAs Oncoheroes prepares to evaluate the efficacy of its lead compound, volasertib, across five pediatric cancer indications, including rhabdomyosarcoma, the Super Sam Foundation once again steps forwar...
Read moreA study led by the I3PT finds that not following a restrictive diet before a colonoscopy does not affect quality or efficiency parameters, and improves tolerability and patient satisfaction
Read moreLaura Soucek, an ICREA Research Professor, Director of VHIO’s Experimental Therapeutics Program, and Head of our Models of Cancer Therapies Group, has received a European Research Council (ERC) Adv...
Read moreThe new regimen has the same efficacy as the standard regimen, but only a quarter of the duration, which reduces the percentage of dropouts and side effects.
Read more